Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2008
07/09/2008CN101218228A Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts
07/09/2008CN101218227A Heterocyclic sulfonamide derivatives as inhibitors of factor xa
07/09/2008CN101218226A Bicyclic derivatives as modulators of ion channels
07/09/2008CN101218209A Benzimidazole derivatives for treatment of inflammatory diseases
07/09/2008CN101218206A Histamine H3 receptor antagonists
07/09/2008CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2
07/09/2008CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
07/09/2008CN100400518C Phthalazinone derivatives
07/09/2008CN100400516C Process for the preparation of pesticidal compounds
07/09/2008CN100400513C Phenylalanine enamide derivatives
07/09/2008CN100400509C Pyrrolidone derivatives as MAOB inhibitors
07/09/2008CN100400040C Tripeptidyl peptidase inhibitors
07/08/2008WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/08/2008US7396936 Modulators of calcitonin and amylin receptor activity
07/08/2008US7396935 p38 kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
07/08/2008US7396928 Crystals of 5-[2-amino-4-(2-furyl) pyrimidin-5-yl]-1-methylpyridin-2(1H)-one and processes for preparing the same
07/08/2008US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/08/2008US7396841 Injections
07/08/2008US7396840 Chemokine receptor binding heterocyclic compounds
07/08/2008US7396839 Heating in solvent; controlling temperature; cooling; isolation; drying
07/08/2008US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
07/08/2008US7396836 Pyrimidine compound and medicinal composition thereof
07/08/2008US7396832 Inhibitors of Akt activity
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008CA2710043A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/08/2008CA2432131C Pyrazole compounds useful as protein kinase inhibitors
07/08/2008CA2420177C Quinazoline derivatives as alpha-1 adrenergic antagonists
07/08/2008CA2402635C Method for oxidizing a thioether group into a sulfoxide group
07/08/2008CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
07/08/2008CA2307391C A process for the preparation of chiral imidazolinone herbicides
07/03/2008WO2008080056A2 Pyridazinones and furan-containing compounds
07/03/2008WO2008079968A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
07/03/2008WO2008079933A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
07/03/2008WO2008079918A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
07/03/2008WO2008079907A1 Compositions and methods for inhibition of the jak pathway
07/03/2008WO2008079857A1 Crystalline forms of aryl-substituted pyrazole-amide compounds
07/03/2008WO2008079759A1 Bicyclic lactam factor viia inhibitors useful as anticoagulants
07/03/2008WO2008079600A1 Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
07/03/2008WO2008079371A1 Modulators of c3a receptor and methods of use thereof
07/03/2008WO2008079316A1 Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof
07/03/2008WO2008079294A1 Substituted heterocycles and methods of use
07/03/2008WO2008079293A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
07/03/2008WO2008079292A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
07/03/2008WO2008079284A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
07/03/2008WO2008079279A1 Heterocyclic compounds with cxcr3 antagonist activity
07/03/2008WO2008079277A1 Certain pyrazoline derivatives with kinase inhibitory activity
07/03/2008WO2008079105A1 Methods to synthesize indoles as precursors for pharmaceuticals
07/03/2008WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
07/03/2008WO2008079028A1 Azetidine analogues of nucleosidase and phosphorylase inhibitors
07/03/2008WO2008078208A1 2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect
07/03/2008WO2008077866A1 Process for manufacturing microcrystalline lansoprazole form i
07/03/2008WO2008077797A1 Processes for the preparation of (3r, 4r) -n- (4 -chlorophenyl) -1- (2, 2-difluoroethyl) -n' - [2-fluoro-4- (2-oxo-1 (2h) -pyridinyl) phenyl] -3, 4-pyrrolidinedicarboxamide
07/03/2008WO2008077554A1 Cycloalkylamine substituted isoquinoline derivatives
07/03/2008WO2008077553A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
07/03/2008WO2008077552A1 Substituted isoquinoline and isoquinolinone derivatives
07/03/2008WO2008077551A1 Cycloalkylamine substituted isoquinolone derivatives
07/03/2008WO2008077550A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
07/03/2008WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
07/03/2008WO2008060927A3 Hepatitis c virus inhibitors
07/03/2008WO2008060927A2 Hepatitis c virus inhibitors
07/03/2008WO2008057291A3 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof
07/03/2008WO2008049919A3 Rho kinase inhibitors
07/03/2008WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles
07/03/2008WO2008002676A9 Biaryl compositions and methods for modulating a kinase cascade
07/03/2008WO2007143434A3 Indazole and isoindole derivatives as glucokinase activating agents
07/03/2008WO2007114902A3 Alkylthiobenzylpiperidine compounds
07/03/2008WO2007113322A3 Substituted 5-hetarylpyrimidines for combating plant pathogenic fungi and cancers
07/03/2008US20080161579 Preparation of rabeprazole sodium by oxidation of wet or dry rabeprazole sulphide with sodium hypohalite in water or a mixture of water and water miscible solvent using alkali metal hydroxide and catalyst; efficient, industrially and environmentally safe
07/03/2008US20080161571 Reacting 4-piperidino-piperidine with phosgene in methylene chloride; reduced dimers formed; intermediate for irinotecan
07/03/2008US20080161565 Coupling [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid with N-(Isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl) Pyridine-3-sulphonamide, producing N-(isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide
07/03/2008US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
07/03/2008US20080161558 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics
07/03/2008US20080161542 Bridgehead Labelled Compounds and Methods of Using the Same
07/03/2008US20080161374 Pyrazole compounds and uses related thereto
07/03/2008US20080161359 Crystalline form of rabeprazole sodium
07/03/2008US20080161353 8-Hydroxy quinoline derivatives
07/03/2008US20080161344 Melanin Concentrating Hormone Receptor Ligands: Substituted Tetrahydroisoquinoline Analogues
07/03/2008US20080161340 Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof
07/03/2008US20080161333 e.g.1'-[(6-chloro-1H-indol-3-yl)carbonyl]-7H-spiro[pentane[3,4-b]pyridine-5,4'-piperidine]; vasopressin V1a receptor antagonist; antidepressant and anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome
07/03/2008US20080161332 e.g.1'-[(6-chloro-1H-indol-3-yl)carbonyl]-7H-spiro[furo[3,4-b]pyridine-5,4'-piperidine]; vasopressin V1a receptor antagonist; antidepressant and anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome
07/03/2008US20080161331 e.g. 1-{3-[4-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenoxy]propyl}piperidine; histamine H3 receptor antagonist; anxiolytic agent, antidepressant, cognition activator; neurodegenerative diseases, eating disorder, attention deficit disorder, Alzheimer's, Parkinson's diseases, schizophrenia
07/03/2008US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080161323 Piperazine Derivatives of Alkyl Oxindoles
07/03/2008US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease
07/03/2008US20080161316 Indoles
07/03/2008US20080161315 Indoles
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008US20080161297 Rho kinase inhibitors
07/03/2008US20080161287 Bicyclic compound, production and use thereof
07/03/2008US20080161280 Inhibitors of poly(adp-ribose)polymerase
07/03/2008US20080160106 Novel Uses for Proton Pump Inhibitors
07/03/2008CA2674525A1 Azetidine analogues of nucleosidase and phosphorylase inhibitors
07/03/2008CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors
07/03/2008CA2673920A1 Cycloalkylamine substituted isoquinoline derivatives
07/03/2008CA2673919A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
07/03/2008CA2673918A1 Substituted isoquinoline and isoquinolinone derivatives
07/03/2008CA2673917A1 Cycloalkylamine substituted isoquinolone derivatives
07/03/2008CA2673916A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
07/03/2008CA2673410A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 1080